Trial intelligence / Profile preview

Phase II open-label single-arm study of HA121-28 in advanced medullary thyroid cancer

CTR20210310Phase 2Terminated

Sponsor

CSPC ZhongQi Pharmaceutical Technology

Start

Jul 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1